Endometriosis Trial, Recruiting NCT06553989 Sponsor: University Hospital, Clermont-Ferrand Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06553989
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who is 18 years of age or older (legal adult)
  • You have been told by your doctor that you need surgery for deep/infiltrating endometriosis
  • You are able and willing to give your consent to take part in research
  • You are already enrolled in a national endometriosis registry program called "NO ENDO," which is run by Clermont-Ferrand University Hospital (confirm with trial site)

Who may not be able to join:

  • Your endometriosis has been described by your doctor as "superficial" (rather than deep/infiltrating)
  • You are a legal adult but are under guardianship or trusteeship (meaning someone else helps manage your affairs legally)
  • You are currently pregnant or breastfeeding
  • You are not registered with the French social security system
  • You do not speak French
  • You are currently under court protection (a legal arrangement to protect your rights or interests)
  • You are already taking part in another research study at the same time
  • You do not wish to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicolas Bourdel, University Hospital, Clermont-Ferrand

Phone: 334.73.754.963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 January 2025
Est. completion
1 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Quality of life with the EHP-30 questionnaire score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov